10.5603/GP.2016.0095 [DOI] [PubMed] [Google Scholar] 29.Anisimov VN, Khavinson VK, Provinciali M, Alimova IN, Baturin DA, Popovich IG, Zabezhinski MA, Imyanitov EN, Mancini R, Franceschi C
GHK-Cu can change pathological gene expression to a healthy mode, mainly in chronic conditions as metastatic cancer, COPD and Ulcerative Colitis
The compound has been studied in trials lasting up to 68 weeks, which provides useful medium-term data but leaves questions about effects beyond 2 years of continuous use
Anecdotal Efficacy Aggregation We synthesize hundreds of user self-reports and biohacker logs to confirm biological activity and healing acceleration
Do not take/receive a double dose to make up for forgotten individual doses